Screener / SEC EDGAR /CIK 0000903129 /10-K filed Feb 19, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Consumer discretionary · Auto Parts

Gentherm Inc THRM

Compare with peers Embed
Earnings releases

Latest results release: Oct 22, 2026

8-K item 2.02, exhibit 99

What THRM's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Oct 22, 2026, THRM reported −$0.08 per share under GAAP and $0.33 on its own adjusted basis.

GAAP EPS $0.47, release Apr 30, 2024: excluding the impact of foreign currency translation, automotive revenues decreased 1.5% year over year GAAP diluted earnings per share was $0.47 as compared with $0.24 for the prior- y Adjusted EPS $0.62, release Apr 30, 2024: year GAAP diluted earnings per share was $0.47 as compared with $0.24 for the prior- year period Adjusted diluted earnings per share (see table herein) was $0.62. +32% 2024-04 GAAP EPS $0.51, release Oct 30, 2024: excluding the impact of foreign currency translation, automotive revenues increased 0.7% year over year GAAP diluted earnings per share was $0.51 as compared with $0.48 for the prior- y Adjusted EPS $0.75, release Oct 30, 2024: year GAAP diluted earnings per share was $0.51 as compared with $0.48 for the prior- year period Adjusted diluted earnings per share (see table herein) was $0.75. +47% 2024-10 GAAP EPS $0.49, release Feb 19, 2025: excluding the impact of foreign currency translation, automotive revenues decreased 3.7% year over year GAAP diluted earnings per share was $0.49 as compared with $0.56 for the prior- year period Adjusted diluted earnings per share was $0.29. Adjusted EPS $0.29, release Feb 19, 2025: excluding the impact of foreign currency translation, automotive revenues decreased 3.7% year over year GAAP diluted earnings per share was $0.49 as compared with $0.56 for the prior- year period Adjusted diluted earnings per share was $0.29. -41% 2025-02 GAAP EPS $-0.00, release Apr 24, 2025: GAAP diluted (loss) earnings per share was $(0.00), compared to $0.47 in the prior year. Adjusted EPS $0.51, release Apr 24, 2025: Adjusted diluted earnings per share was $0.51, compared to $0.62 in the prior year. 2025-04 GAAP EPS $0.02, release Jul 24, 2025: GAAP diluted earnings per share was $0.02, compared to $0.60 in the prior year. Adjusted EPS $0.54, release Jul 24, 2025: Adjusted diluted earnings per share was $0.54, compared to $0.66 in the prior year. +2600% 2025-07 GAAP EPS $0.49, release Oct 23, 2025: GAAP diluted earnings per share was $0.49, compared to $0.51 in the prior year. Adjusted EPS $0.73, release Oct 23, 2025: Adjusted diluted earnings per share was $0.73, compared to $0.75 in the prior year. +49% 2025-10 GAAP EPS $0.10, release Feb 19, 2026: GAAP diluted earnings per share was $0.10, compared to $0.49 in the prior year. Adjusted EPS $0.49, release Feb 19, 2026: Adjusted diluted earnings per share was $0.49,compared to $0.29 in the prior year. +390% 2026-02 GAAP EPS $-0.08, release Oct 22, 2026: GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the prior year. Adjusted EPS $0.33, release Oct 22, 2026: Adjusted diluted earnings per share was $0.33,compared to $0.73 in the prior year. 2026-10
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the prior year. release
Adjusted diluted earnings per share was $0.33,compared to $0.73 in the prior year. release

What the company says its adjusted numbers leave out:

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); free cash flow; net capital expenditures (“net CAPEX”); Net Debt; liquidity; net leverage ratio (“net leverage”); revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; and adjusted operating expenses, each a non-GAAP financial measure. release Oct 23, 2025

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Oct 22, 2026 · EX-99.1

Gentherm Reports 2026 Third Quarter Results

Open on SEC

Repurchased $60 Million of Common Stock in October NOVI, Michigan, October 22, 2026 -- Gentherm (NASDAQ:THRM), a global leader of innovative thermal and precision flow management technologies, today announced its financial results for the third quarter ended September 30, 2026.

“Our third quarter results were in line with expectations as we made continued progress on growth and operational excellence initiatives, while completing the Modine Performance Technologies combination on October 1,” said Bill Presley, the Company's President and CEO. “With the completion of the transaction, we are fundamentally a different company. We are entering an exciting new phase for Gentherm with industry leading platforms and I am increasingly confident in the significant value creation opportunities ahead.”

Expanded portfolio of differentiated technologies with launch of ThermAffyx™ Patient Safety System and Puls.A™.

Product revenues of $405.1 million increased 4.7% from $386.9 million in the prior year. Excluding the impact of foreign currency translation, product revenues increased 4.4%.

Automotive Climate and Comfort Solutions revenue increased 8.8% year over year, or 8.5% excluding the impact of foreign currency translation, outperforming S&P Global’s mid-October light vehicle production report in our relevant markets by 12 percentage points.

Gross margin was 23.3%, compared to 24.6% in the prior year. The decrease was primarily driven by foreign exchange, higher net material costs and inflation, partially offset by strong operating leverage.

Net (loss) income was $(2.6) million, compared to $14.9 million in the prior year.

Adjusted EBITDA was $45.0 million, or 11.1% of revenue, compared to $49.0 million, or 12.7% of revenue, in the prior year.

GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the prior year.

Adjusted diluted earnings per share was $0.33,compared to $0.73 in the prior year.

Cash flow from operations was $36.0 million, compared to $87.8 million in the prior year.

Adjusted free cash flow was $59.5 million, compared to $72.3 million in the prior year.

The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures. Guidance The Company updated its full year 2026 guidance to reflect the expected contribution from Modine Performance Technologies in the fourth quarter¹.

¹2026 guidance based on tariffs currently in effect as of today, our current forecast of customer demand and expectations of near-term conditions, light vehicle production in our relevant markets decreasing at a low single digit rate for full year 2026 versus 2025, and a EUR to USD exchange rate of $1.15/Euro. Capital Allocation Update • On July 1, acquired Innovative Medical Equipment, LLC, provider of the ThermaZone® thermal therapy device, expanding thermal management product portfolio and providing strong cross-selling opportunities by leveraging complementary customer bases across additional healthcare channels. • On October 1, completed combination with Modine’s Performance Technologies business. • On October 7, returned $63.5 million to shareholders through a special cash dividend of $2.07 per share as part of the Modine transaction. • In July, the Board of Directors authorized a new stock repurchase program of up to $400 million of the Company’s issued and outstanding common stock. Following the closing of the transaction with Modine in October, the Company repurchased $60 million of common stock. As of today, the program has approximately $340 million of stock repurchase authorization remaining. • Third quarter ended with net leverage of ~0.4x and liquidity of $494.2 million. “As expected, following the combination with Modine Performance Technologies, we remain in a strong financial position and continue to have confidence in the ability to generate significant cash moving forward,” said Jon Douyard, the Company’s Chief Financial Officer. “We believe the current share price does not reflect the value of the Company. We previously communicated our intention to repurchase shares following the Modine transaction. Since closing, we have repurchased $60 million and we remain committed to returning capital to shareholders, particularly in times of value dislocation.” Conference Call As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside the U.S.). The passcode for the live call is 13763267. A live webcast and one-year archived replay of the call, as well as a copy of the supplemental materials that will be used during the conference call, can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on November 5, 2026. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13763267. Investor ContactGregory [email protected]

Gentherm (NASDAQ: THRM) is a global leader of innovative thermal and precision flow management technologies. The Company brings together industry leading products from Gentherm’s climate, comfort and valves businesses serving the light vehicle, medical, and home and office markets, with Modine’s highly engineered, mission-critical thermal solutions serving commercial vehicle, off- highway equipment, light vehicle and power generation markets. Gentherm has more than 18,000 employees in facilities across 17 countries. For more information, go towww.gentherm.com.

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, third party information and projections from sources that management believes to be reputable, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;

the impact of, and our ability to mitigate the effects of, global economic and trade policies, including increases in duties, tariffs and taxation on the import or export of our products related to U.S. trade disputes;

increasing U.S. and global competition, including with non-traditional entrants;

our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;

the evolution and challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;

the constraints in the supply chain environment, and inflationary and other cost pressures;

the production levels of our major customers and OEMs in our relevant markets and sudden fluctuations in such production levels;

our business in China, which is subject to unique operational, competitive, geopolitical, regulatory and economic risks;

the impact of our global operations, including our cost structure and global manufacturing footprint, operations within Ukraine, and foreign currency and exchange risk;

our product quality and safety and impact of product safety recalls and alleged defects in products;

a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;

our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;

our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production;

our ability to source, consummate, integrate and achieve planned benefits of strategic acquisitions, investments and, as applicable, exits;

any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks, including risks associated with use of artificial intelligence capabilities in our business operations;

our ability to project future sales volume based on third-party information, based on which we manage our business;

legal and regulatory proceedings and claims involving us or one of our major customers;

the effects of climate change and regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;

our borrowing availability under our revolving credit facility, as well as the ability to access the capital markets, to support our planned growth; and

Furthermore, important factors related to the combination with Modine Performance Technologies (the “Transaction”) could cause actual results to differ materially from those currently anticipated, including:

uncertainty of the expected financial performance of the combined company following completion of the Transaction;

difficulties and delays in the combined company achieving revenue and cost synergies;

changes in general economic and/or industry specific conditions or any volatility resulting from the imposition of and changing policies, including those policies with respect to tariffs; and

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; Adjusted net income; Adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); Quarter- to-date Operating Cash Flow; Free Cash Flow; Adjusted Free Cash Flow; Adjusted Free Cash Flow Conversion rate; net capital expenditures (“net CAPEX”); Net Debt; Liquidity; Net Leverage Ratio (“Net Leverage”); revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Adjusted operating expenses; Pro Forma Revenue; Pro Forma Adjusted EBITDA; and Pro Forma Adjusted EBITDA Margin, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted net income as earnings adjusted by restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EPS as Adjusted net income divided by the Company’s weighted average shares outstanding. The Company defines Quarter-to-date Operating Cash Flow as Net cash provided by/(used in) operating activities for the current period, less that of the immediately preceding period. The Company defines Free Cash Flow as Net cash provided by/(used in) operating activities plus Proceeds from the sale of property and equipment less Purchases of property and equipment. The Company defines net CAPEX as Purchases of property and equipment less Proceeds from the sale of property and

equipment. The Company defines Adjusted Free Cash Flow as Net cash provided by/(used in) operating activities, excluding cash restructuring expenses, net and other gains and losses not reflective of the Company’s ongoing operations, less net CAPEX. The Company defines Adjusted Free Cash Flow Conversion rate as Adjusted Free Cash Flow divided by Adjusted EBITDA. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines Liquidity as the sum of cash and cash equivalents and availability under the Company’s revolving line of credit. The Company defines Net Leverage as Net Debt divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified. The Company defines Adjusted operating expenses as operating expenses excluding related non-cash stock based compensation, restructuring expenses, net, and other gains and losses not reflective of the Company’s ongoing operations. The Company defines Pro Forma Revenue as Gentherm’s product revenues for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Net sales for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure. The Company defines Pro Forma Adjusted EBITDA as Gentherm’s Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure and go-forward operational alignment. The Company defines Pro Forma Adjusted EBITDA Margin as Pro Forma Adjusted EBITDA divided by Pro Forma Revenue.

The Company’s reconciliations are included in this release or can be found in the supplemental materials for this reporting period on the Company’s website.

In evaluating its business, the Company considers and uses Quarter-to-date Operating Cash Flow, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Net Debt, Net Leverage and Liquidity as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income/(loss), revenue or other consolidated income/(loss) statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Adjusted EPS, Pro Forma Revenue, Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results. GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF (LOSS) INCOME (Dollars in thousands, except per share data) (Unaudited)

GENTHERM INCORPORATED REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT (Dollars in thousands) (Unaudited)

GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN (Dollars in thousands) (Unaudited)

GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (Dollars in thousands, except per share data) (Unaudited)

GENTHERM INCORPORATED CONSOLIDATED CONDENSED BALANCE SHEETS (Dollars in thousands, except share data) (Unaudited)

September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS Current Assets: Cash and cash $ 252,098 $ 160,833 equivalents Accounts receivable, 326,217 281,083 net Inventory: Raw materials 127,403 128,314 Work in process 44,437 35,429 Finished goods 91,647 88,959 Inventory, net 263,487 252,702 Other current assets 85,678 82,332 Total current assets 927,480 776,950 Property and 263,561 270,614 equipment, net Goodwill 122,258 108,918 Other intangible 63,858 52,796 assets, net Operating lease 48,674 56,524 right-of-use assets Deferred income tax 93,853 93,552 assets Other non-current 42,615 37,075 assets Total assets $ 1,562,299 $ 1,396,429 LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Accounts payable $ 298,183 $ 260,487 Current lease 7,846 9,646 liabilities Current maturities of 912 73 long-term debt Other current 144,999 134,104 liabilities Total current 451,940 404,310 liabilities Long-term debt, less 319,531 189,000 current maturities Non-current lease 42,469 48,105 liabilities Pension benefit 3,281 3,748 obligation Other non-current 23,760 30,943 liabilities Total liabilities $ 840,981 $ 676,106 Shareholders’ Equity: Common Stock: No par value; 110,000,000 shares authorized 30,710,902 and 30,526,231 issued and 13,442 5,611 outstanding at September 30, 2026 and December 31, 2025, respectively Paid-in capital 1,590 1,590 Accumulated other (13,848 ) (964 ) comprehensive loss Accumulated earnings 720,134 714,086 Total shareholders’ 721,318 720,323 equity Total liabilities and shareholders’ $ 1,562,299 $ 1,396,429 equity

GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited)

Nine Months Ended Operating September 30, Activities: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 6,048 $ 15,298 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and 44,201 39,478 amortization Deferred income (9,548 ) (12,836 ) taxes Stock based 10,371 10,573 compensation Loss on disposition of property and 121 2,671 equipment Provisions for 4,086 5,234 inventory Other non-cash items, including unrealized foreign (1,018 ) 30,957 currency (gain) loss Changes in assets and liabilities: Accounts (43,474 ) (20,543 ) receivable, net Inventory (22,133 ) (20,136 ) Other assets (1,403 ) (22,325 ) Accounts payable 43,305 33,514 Other liabilities 5,451 25,935 Net cash provided by operating 36,007 87,820 activities Investing Activities: Purchases of property and (22,558 ) (33,378 ) equipment Proceeds from the sale of property 83 3,770 and equipment Acquisition of business, net of (34,152 ) — cash acquired Cost of technology (121 ) (915 ) investments Proceeds from deferred purchase price of — 744 factored receivables Net cash used in investing (56,748 ) (29,779 ) activities Financing — — Activities: Borrowings on debt 204,000 72,000 Repayments of debt (85,887 ) (103,112 ) Cash paid for (2,761 ) — financing new loans Taxes withheld and paid on employees' (2,540 ) (1,306 ) stock based compensation Cash paid for the repurchase of — (10,015 ) Common Stock Net cash provided by (used in) 112,812 (42,433 ) financing activities Foreign currency (806 ) 4,508 effect Net increase in cash and cash 91,265 20,116 equivalents Cash and cash equivalents at 160,833 134,134 beginning of period Cash and cash equivalents at end $ 252,098 $ 154,250 of period

Full text with the tables
                                                                    Exhibit 99.1
                  Gentherm Reports 2026 Third Quarter Results                   
                                                                                
       Delivered Revenue of $405 Million, up 4.4% (ex-FX) Year-over-Year        
                                                                                
   2026 Full Year Guidance Updated to Include Modine Performance Technologies   
                                                                                
               Repurchased $60 Million of Common Stock in October               
NOVI, Michigan, October 22, 2026 -- Gentherm (NASDAQ:THRM), a global leader of  
innovative thermal and precision flow management technologies, today announced  
its financial results for the third quarter ended September 30, 2026.           
                                                                                
“Our third quarter results were in line with expectations as we made continued  
progress on growth and operational excellence initiatives, while completing the 
Modine Performance Technologies combination on October 1,” said Bill Presley,   
the Company's President and CEO. “With the completion of the transaction, we are
fundamentally a different company. We are entering an exciting new phase for    
Gentherm with industry leading platforms and I am increasingly confident in the 
significant value creation opportunities ahead.”                                
                                                                                
Third Quarter Highlights                                                        
                                                                                
Secured Automotive New Business Awards totaling $555 million in the quarter.    
                                                                                
Expanded portfolio of differentiated technologies with launch of ThermAffyx™    
Patient Safety System and Puls.A™.                                              
                                                                                
Product revenues of $405.1 million increased 4.7% from $386.9 million in the    
prior year. Excluding the impact of foreign currency translation, product       
revenues increased 4.4%.                                                        
                                                                                
Automotive Climate and Comfort Solutions revenue increased 8.8% year over year, 
or 8.5% excluding the impact of foreign currency translation, outperforming S&P 
Global’s mid-October light vehicle production report in our relevant markets by 
12 percentage points.                                                           
                                                                                
Gross margin was 23.3%, compared to 24.6% in the prior year. The decrease was   
primarily driven by foreign exchange, higher net material costs and inflation,  
partially offset by strong operating leverage.                                  
                                                                                
Net (loss) income was $(2.6) million, compared to $14.9 million in the prior    
year.                                                                           
                                                                                
Adjusted EBITDA was $45.0 million, or 11.1% of revenue, compared to $49.0       
million, or 12.7% of revenue, in the prior year.                                
                                                                                
GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the    
prior year.                                                                     
                                                                                
Adjusted diluted earnings per share was $0.33,compared to $0.73 in the prior    
year.                                                                           
                                                                                
Cash flow from operations was $36.0 million, compared to $87.8 million in the   
prior year.                                                                     
                                                                                
Adjusted free cash flow was $59.5 million, compared to $72.3 million in the     
prior year.                                                                     
                                                                                
The Company provides various non-GAAP financial measures in this release. See   
“Use of Non-GAAP Measures” below for additional information, including          
definitions, usefulness for investors and limitations, as well as               
reconciliations below to the most directly comparable GAAP financial measures.  
Guidance The Company updated its full year 2026 guidance to reflect the expected
contribution from Modine Performance Technologies in the fourth quarter¹.
                                                                    
                             As of July 2026    As of October 2026  
  Product Revenues           $1.55B – $1.65B    $1.825B – $1.925B   
  Adjusted EBITDA            $185M – $200M      $210M – $230M       
  Adjusted Free Cash Flow    $85M – $100M       $100M – $120M       
                                                                    
¹2026 guidance based on tariffs currently in effect as of today, our current
forecast of customer demand and expectations of near-term conditions, light
vehicle production in our relevant markets decreasing at a low single digit rate
for full year 2026 versus 2025, and a EUR to USD exchange rate of $1.15/Euro.
Capital Allocation Update • On July 1, acquired Innovative Medical Equipment,
LLC, provider of the ThermaZone® thermal therapy device, expanding thermal
management product portfolio and providing strong cross-selling opportunities by
leveraging complementary customer bases across additional healthcare channels. •
On October 1, completed combination with Modine’s Performance Technologies
business. • On October 7, returned $63.5 million to shareholders through a
special cash dividend of $2.07 per share as part of the Modine transaction. • In
July, the Board of Directors authorized a new stock repurchase program of up to
$400 million of the Company’s issued and outstanding common stock. Following the
closing of the transaction with Modine in October, the Company repurchased $60
million of common stock. As of today, the program has approximately $340 million
of stock repurchase authorization remaining. • Third quarter ended with net
leverage of ~0.4x and liquidity of $494.2 million. “As expected, following the
combination with Modine Performance Technologies, we remain in a strong
financial position and continue to have confidence in the ability to generate
significant cash moving forward,” said Jon Douyard, the Company’s Chief
Financial Officer. “We believe the current share price does not reflect the
value of the Company. We previously communicated our intention to repurchase
shares following the Modine transaction. Since closing, we have repurchased $60
million and we remain committed to returning capital to shareholders,
particularly in times of value dislocation.” Conference Call As previously
announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time
to review these results. The dial-in number for the call is 1-877-407-4018
(callers in the U.S.) or +1-201-689-8471 (callers outside the U.S.). The
passcode for the live call is 13763267. A live webcast and one-year archived
replay of the call, as well as a copy of the supplemental materials that will be
used during the conference call, can be accessed on the Events page of the
Investor section of Gentherm's website at www.gentherm.com. A telephonic replay
will be available approximately two hours after the call until 11:59 pm Eastern
Time on November 5, 2026. The replay can be accessed by dialing 1-844-512-2921
(callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The
passcode for the replay is 13763267.
Investor ContactGregory [email protected]            
                                                                                
Media ContactHaley [email protected]                           
                                                                                
About Gentherm                                                                  
                                                                                
Gentherm (NASDAQ: THRM) is a global leader of innovative thermal and precision  
flow management technologies. The Company brings together industry leading      
products from Gentherm’s climate, comfort and valves businesses serving the     
light vehicle, medical, and home and office markets, with Modine’s highly       
engineered, mission-critical thermal solutions serving commercial vehicle, off- 
highway equipment, light vehicle and power generation markets. Gentherm has more
than 18,000 employees in facilities across 17 countries. For more information,  
go towww.gentherm.com.                                                          
                                                                                
Forward-Looking Statements                                                      
                                                                                
Except for historical information contained herein, statements in this release  
are forward-looking statements that are made pursuant to the safe harbor        
provisions of the Private Securities Litigation Reform Act of 1995. These       
forward-looking statements represent Gentherm Incorporated's goals, beliefs,    
plans and expectations about its prospects for the future and other future      
events. The forward-looking statements included in this release are made as of  
the date hereof or as of the date specified herein and are based on management's
reasonable expectations and beliefs. In making these statements we rely on      
assumptions and analysis based on our experience and perception of historical   
trends, current conditions and expected future developments, third party        
information and projections from sources that management believes to be         
reputable, as well as other factors we consider appropriate under the           
circumstances. Such statements are subject to a number of important assumptions,
significant risks and uncertainties (some of which are beyond our control) and  
other factors that may cause actual results or performance to differ materially 
from that described in or indicated by the forward-looking statements, including
but not limited to:                                                             
                                                                                
macroeconomic, geopolitical and similar global factors in the cyclical          
Automotive industry;                                                            
                                                                                
the impact of, and our ability to mitigate the effects of, global economic and  
trade policies, including increases in duties, tariffs and taxation on the      
import or export of our products related to U.S. trade disputes;                
                                                                                
increasing U.S. and global competition, including with non-traditional entrants;
                                                                                
our ability to effectively manage new product launches and research and         
development, and the market acceptance of such products and technologies;       
                                                                                
the evolution and challenges of the automotive industry towards electric        
vehicles, autonomous vehicles and mobility on demand services, and related      
consumer behaviors and preferences;                                             
                                                                                
our ability to convert automotive new business awards into product revenues;    
                                                                                
the constraints in the supply chain environment, and inflationary and other cost
pressures;                                                                      
                                                                                
the production levels of our major customers and OEMs in our relevant markets   
and sudden fluctuations in such production levels;                              
                                                                                
our business in China, which is subject to unique operational, competitive,     
geopolitical, regulatory and economic risks;                                    
                                                                                
the impact of our global operations, including our cost structure and global    
manufacturing footprint, operations within Ukraine, and foreign currency and    
exchange risk;                                                                  
                                                                                
our product quality and safety and impact of product safety recalls and alleged 
defects in products;                                                            
                                                                                
our ability to attract and retain highly skilled employees and wage inflation;  
                                                                                
a tightening labor market, labor shortages or work stoppages impacting us, our  
customers or our suppliers, such as recent labor strikes among certain OEMs and 
suppliers;                                                                      
                                                                                
our achievement of product cost reductions to offset customer-imposed price     
reductions or other pricing pressures;                                          
                                                                                
our ability to execute efforts to optimize our global supply chain and          
manufacturing footprint, including opening new facilities and transferring      
production;                                                                     
                                                                                
our ability to source, consummate, integrate and achieve planned benefits of    
strategic acquisitions, investments and, as applicable, exits;                  
                                                                                
any security breaches and other disruptions to our information technology       
networks and systems, as well as privacy, data security and data protection     
risks, including risks associated with use of artificial intelligence           
capabilities in our business operations;                                        
                                                                                
any loss or insolvency of our key customers and OEMs, or key suppliers;         
                                                                                
our ability to project future sales volume based on third-party information,    
based on which we manage our business;                                          
                                                                                
the protection of our intellectual property in certain jurisdictions;           
                                                                                
our compliance with global anti-corruption laws and regulations;                
                                                                                
legal and regulatory proceedings and claims involving us or one of our major    
customers;                                                                      
                                                                                
the extensive regulation of our patient temperature management business;        
                                                                                
risks associated with our manufacturing processes;                              
                                                                                
the effects of climate change and regulatory and stakeholder-imposed            
requirements to address climate change and other sustainability issues;         
                                                                                
our product quality and safety;                                                 
                                                                                
our borrowing availability under our revolving credit facility, as well as the  
ability to access the capital markets, to support our planned growth; and       
                                                                                
our indebtedness and compliance with our debt covenants.                        
                                                                                
Furthermore, important factors related to the combination with Modine           
Performance Technologies (the “Transaction”) could cause actual results to      
differ materially from those currently anticipated, including:                  
                                                                                
uncertainty of the expected financial performance of the combined company       
following completion of the Transaction;                                        
                                                                                
failure to realize the anticipated benefits of the Transaction;                 
                                                                                
the ability of the combined company to implement its business strategy;         
                                                                                
difficulties and delays in the combined company achieving revenue and cost      
synergies;                                                                      
                                                                                
inability of the combined company to retain and hire key personnel;             
                                                                                
evolving legal, regulatory and tax regimes;                                     
                                                                                
changes in general economic and/or industry specific conditions or any          
volatility resulting from the imposition of and changing policies, including    
those policies with respect to tariffs; and                                     
                                                                                
actions by third parties, including government agencies.                        
                                                                                
The foregoing risks should be read in conjunction with the Company's reports    
filed with or furnished to the Securities and Exchange Commission (the “SEC”),  
including “Risk Factors,” in its most recent Annual Report on Form 10-K and     
subsequent SEC filings, for a discussion of these and other risks and           
uncertainties. In addition, with reasonable frequency, we have entered into     
business combinations, acquisitions, divestitures, strategic investments and    
other significant transactions. Such forward-looking statements do not include  
the potential impact of any such transactions that may be completed after the   
date hereof, each of which may present material risks to the Company’s future   
business and financial results. Moreover, we operate in a very competitive and  
rapidly changing environment and new risks emerge from time to time.            
                                                                                
Except as required by law, the Company expressly disclaims any obligation or    
undertaking to update any forward-looking statements to reflect any change in   
its strategies or expectations with regard thereto or any change in events,     
conditions or circumstances on which any such statement is based.               
                                                                                
Use of Non-GAAP Financial Measures                                              
                                                                                
In addition to the results reported in accordance with GAAP throughout this     
release, the Company has provided here or elsewhere information regarding:      
adjusted earnings before interest, taxes, depreciation and amortization         
(“Adjusted EBITDA”); Adjusted EBITDA margin; Adjusted net income; Adjusted      
earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); Quarter-  
to-date Operating Cash Flow; Free Cash Flow; Adjusted Free Cash Flow; Adjusted  
Free Cash Flow Conversion rate; net capital expenditures (“net CAPEX”); Net     
Debt; Liquidity; Net Leverage Ratio (“Net Leverage”); revenue, segment revenue  
and product revenue excluding foreign currency translation and other specified  
gains and losses; Adjusted operating expenses; Pro Forma Revenue; Pro Forma     
Adjusted EBITDA; and Pro Forma Adjusted EBITDA Margin, each a non-GAAP financial
measure. The Company defines Adjusted EBITDA as earnings before interest, taxes,
depreciation and amortization, deferred financing cost amortization, non-cash   
stock based compensation expenses, restructuring expenses, net, unrealized      
currency gain or loss and other gains and losses not reflective of the Company’s
ongoing operations and related tax effects. The Company defines Adjusted EBITDA 
margin as Adjusted EBITDA divided by product revenues. The Company defines      
Adjusted net income as earnings adjusted by restructuring expenses, net,        
unrealized currency gain or loss and other gains and losses not reflective of   
the Company’s ongoing operations and related tax effects. The Company defines   
Adjusted EPS as Adjusted net income divided by the Company’s weighted average   
shares outstanding. The Company defines Quarter-to-date Operating Cash Flow as  
Net cash provided by/(used in) operating activities for the current period, less
that of the immediately preceding period. The Company defines Free Cash Flow as 
Net cash provided by/(used in) operating activities plus Proceeds from the sale 
of property and equipment less Purchases of property and equipment. The Company 
defines net CAPEX as Purchases of property and equipment less Proceeds from the 
sale of property and                                                            
                                                                                
equipment. The Company defines Adjusted Free Cash Flow as Net cash provided     
by/(used in) operating activities, excluding cash restructuring expenses, net   
and other gains and losses not reflective of the Company’s ongoing operations,  
less net CAPEX. The Company defines Adjusted Free Cash Flow Conversion rate as  
Adjusted Free Cash Flow divided by Adjusted EBITDA. The Company defines Net Debt
as the principal amount of all Consolidated Funded Indebtedness (as defined in  
the Credit Agreement) less cash and cash equivalents. The Company defines       
Liquidity as the sum of cash and cash equivalents and availability under the    
Company’s revolving line of credit. The Company defines Net Leverage as Net Debt
divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company   
defines revenue, segment revenue or product revenue excluding foreign currency  
translation and other specified gains and losses as such revenue, excluding the 
estimated effects of foreign currency exchange on revenue by translating actual 
revenue using the prior period foreign currency exchange rates and excluding the
other items specified. The Company defines Adjusted operating expenses as       
operating expenses excluding related non-cash stock based compensation,         
restructuring expenses, net, and other gains and losses not reflective of the   
Company’s ongoing operations. The Company defines Pro Forma Revenue as          
Gentherm’s product revenues for the trailing four fiscal quarters (from the date
specified), plus Modine Performance Technologies’ Net sales for the trailing    
four fiscal quarters (from the date specified), as reported by Modine           
Manufacturing Company, adjusted to reflect the latest business structure. The   
Company defines Pro Forma Adjusted EBITDA as Gentherm’s Adjusted EBITDA for the 
trailing four fiscal quarters (from the date specified), plus Modine Performance
Technologies’ Adjusted EBITDA for the trailing four fiscal quarters (from the   
date specified), as reported by Modine Manufacturing Company, adjusted to       
reflect the latest business structure and go-forward operational alignment. The 
Company defines Pro Forma Adjusted EBITDA Margin as Pro Forma Adjusted EBITDA   
divided by Pro Forma Revenue.                                                   
                                                                                
The Company’s reconciliations are included in this release or can be found in   
the supplemental materials for this reporting period on the Company’s website.  
                                                                                
In evaluating its business, the Company considers and uses Quarter-to-date      
Operating Cash Flow, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash
Flow Conversion rate, Net Debt, Net Leverage and Liquidity as supplemental      
measures of its liquidity and the other non-GAAP financial measures as          
supplemental measures of its operating performance. Management provides such    
non-GAAP financial measures so that investors will have the same financial      
information that management uses with the belief that it will assist investors  
in properly assessing the Company's performance on a period-over-period basis by
excluding matters not indicative of the Company’s ongoing operating or liquidity
results and therefore enhance the comparability of the Company's results and    
provide additional information for analyzing trends in the business. In         
evaluating our non-GAAP financial measures, you should be aware that in the     
future we may incur revenues, expenses, and cash and non-cash obligations that  
are the same as or similar to some of the adjustments in our presentation of    
non-GAAP financial measures. Our presentation of non-GAAP financial measures    
should not be construed as an inference that our future results will be         
unaffected by unusual or non-recurring items. There also can be no assurance    
that we will not modify the presentation of our non-GAAP financial measures in  
the future, and any such modification may be material. Other companies in our   
industry may define and calculate these non-GAAP financial measures differently 
than we do and those calculations may not be comparable to our metrics. These   
non-GAAP measures have limitations as analytical tools, and when assessing the  
Company's operating performance or liquidity, investors should not consider     
these non-GAAP measures in isolation, or as a substitute for net income/(loss), 
revenue or other consolidated income/(loss) statement or cash flow statement    
data prepared in accordance with GAAP.                                          
                                                                                
Non-GAAP measures referenced in this release and other public communications may
include estimates of future Adjusted EBITDA, Adjusted EBITDA margin, Adjusted   
Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Adjusted EPS, Pro Forma
Revenue, Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin. The    
Company has not reconciled the non-GAAP forward-looking guidance included in    
this release to the most directly comparable GAAP measures because this cannot  
be done without unreasonable effort due to the variability and low visibility   
with respect to taxes and non-recurring items, which are potential adjustments  
to future earnings. We expect the variability of these items to have a          
potentially unpredictable, and a potentially significant, impact on our future  
GAAP financial results.                                                         
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF (LOSS) INCOME
(Dollars in thousands, except per share data) (Unaudited)
                                                                                
                Three                                Nine                       
                Mont…                               Mont…                       
                Ended                               Ended                       
                Sept…                               Sept…                       
          2026    30,       2025              2026    30,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Pro…    $     405,…       $     386,…       $     1,21…       $     1,11…     
  rev…                                                                          
  Cost                                                                          
  of            310,…             291,…             927,…             844,…     
  sal…                                                                          
  Gro…          94,3…             95,1…             287,…             271,…     
  mar…                                                                          
  Ope…                                                                          
  exp…                                                                          
  Net                                                                           
  res…                                                                          
  and           23,4…             24,4…             71,4…             71,2…     
  dev…                                                                          
  exp…                                                                          
  Sel…                                                                          
  gen…                                                                          
  and           51,6…             42,8…             162,…             122,…     
  adm…                                                                          
  exp…                                                                          
  Res…                                                                          
  exp…          4,838             3,986             17,4…             10,6…     
  net                                                                           
  Loss                                                                          
  on                                                                            
  sale                                                                          
  of                —                 —                 —             2,196     
  land                                                                          
  and                                                                           
  bui…                                                                          
  net                                                                           
  Tot…                                                                          
  ope…          79,9…             71,2…             251,…             206,…     
  exp…                                                                          
  Ope…          14,3…             23,8…             36,3…             64,9…     
  inc…                                                                          
  Int…                                                                          
  exp…          (3,8…  )          (3,3…  )          (9,7…  )          (10,…  )  
  net                                                                           
  For…                                                                          
  cur…            193               339             (1,1…  )          (27,…  )  
  gain                                                                          
  (lo…                                                                          
  Oth…                                                                          
  inc…            116                 —               300             (1,1…  )  
  (lo…                                                                          
  Ear…                                                                          
  bef…          10,8…             20,8…             25,7…             25,5…     
  inc…                                                                          
  tax                                                                           
  Inc…                                                                          
  tax           13,4…             5,935             19,7…             10,2…     
  exp…                                                                          
  Net                                                                           
  (lo…    $     (2,5…  )    $     14,9…       $     6,048       $     15,2…     
  inc…                                                                          
  Bas…                                                                          
  (lo…                                                                          
  ear…    $     (0.08  )    $      0.49       $      0.20       $      0.50     
  per                                                                           
  sha…                                                                          
  Dil…                                                                          
  (lo…                                                                          
  ear…    $     (0.08  )    $      0.49       $      0.19       $      0.50     
  per                                                                           
  sha…                                                                          
  Wei…                                                                          
  ave…                                                                          
  num…                                                                          
  of            30,6…             30,4…             30,6…             30,6…     
  sha…                                                                          
  –                                                                             
  bas…                                                                          
  Wei…                                                                          
  ave…                                                                          
  num…                                                                          
  of            30,6…             30,7…             31,0…             30,8…     
  sha…                                                                          
  –                                                                             
  dil…                                                                          
                                                                                
GENTHERM INCORPORATED REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN
CURRENCY TRANSLATION IMPACT (Dollars in thousands) (Unaudited)
                                                                                
            Th…                                  Ni…                            
            Mo…                                  Mo…                            
            En…                                  En…                            
            Se…               %                  Se…               %            
        2…  30,    2…         C…             2…  30,    2…         C…           
 ────────────────────────────────────────────────────────────────────────────── 
  C…                                                                            
  C…    $   21…    $   20…        7.1  %     $   63…    $   59…        8.0  %   
  S…                                                                            
  L…                                                                            
  a…                                                                            
  M…        70…        55…        27…  %         20…        15…        33…  %   
  C…                                                                            
  S…                                                                            
  C…                                                                            
  C…        51…        52…        (1…  )%        15…        14…        5.2  %   
  I…                                                                            
  C…                                                                            
  a…        7,…        8,…        (7…  )%        25…        22…        16…  %   
  C…                                                                            
  E…                                                                            
  A…                                                                            
  C…                                                                            
  a…        34…        31…        8.8  %         1,…        91…        12…  %   
  C…                                                                            
  S…                                                                            
  V…        21…        24…        (1…  )%        73…        72…        0.6  %   
  S…                                                                            
  O…        22…        31…        (2…  )%        77…        91…        (1…  )%  
  A…                                                                            
  S…                                                                            
  A…        39…        37…        4.4  %         1,…        1,…        9.0  %   
  s…                                                                            
  M…        14…        12…        14…  %         37…        35…        4.2  %   
  s…                                                                            
  T…    $   40…    $   38…        4.7  %     $   1,…    $   1,…        8.9  %   
  C…                                                                            
  F…                                                                            
  c…                                                                            
  t…        1,…          —                       20…          —                 
  i…                                                                            
  (…                                                                            
  T…                                                                            
  C…                                                                            
  e…                                                                            
  f…    $   40…    $   38…        4.4  %     $   1,…    $   1,…        7.0  %   
  c…                                                                            
  t…                                                                            
  i…                                                                            
  (…                                                                            
  F…                                                                            
  c…                                                                            
  t…                                                                            
  i…                                                                            
  f…                                                                            
  t…                                                                            
  A…                                                                            
  s…                                                                            
  a…                                                                            
  M…                                                                            
  s…                                                                            
  w…                                                                            
  $…                                                                            
  a…                                                                            
  $…                                                                            
  r…                                                                            
  f…                                                                            
  t…                                                                            
  t…                                                                            
  m…                                                                            
  e…                                                                            
  S…                                                                            
  3…                                                                            
  2…                                                                            
  F…                                                                            
  c…                                                                            
  t…                                                                            
  i…                                                                            
  f…                                                                            
  A…                                                                            
  C…                                                                            
  a…                                                                            
  C…                                                                            
  S…                                                                            
  w…                                                                            
  $…                                                                            
  f…                                                                            
  t…                                                                            
  t…                                                                            
  m…                                                                            
  e…                                                                            
  S…                                                                            
  3…                                                                            
  2…                                                                            
  F…                                                                            
  c…                                                                            
  t…                                                                            
  i…                                                                            
  f…                                                                            
  t…                                                                            
  A…                                                                            
  s…                                                                            
  a…                                                                            
  M…                                                                            
  s…                                                                            
  w…                                                                            
  $…                                                                            
  a…                                                                            
  $…                                                                            
  r…                                                                            
  f…                                                                            
  t…                                                                            
  n…                                                                            
  m…                                                                            
  e…                                                                            
  S…                                                                            
  3…                                                                            
  2…                                                                            
  F…                                                                            
  c…                                                                            
  t…                                                                            
  i…                                                                            
  f…                                                                            
  A…                                                                            
  C…                                                                            
  a…                                                                            
  C…                                                                            
  S…                                                                            
  w…                                                                            
  $…                                                                            
  f…                                                                            
  t…                                                                            
  n…                                                                            
  m…                                                                            
  e…                                                                            
  S…                                                                            
  3…                                                                            
  2…                                                                            
                                                                                
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED EBITDA AND
ADJUSTED EBITDA MARGIN (Dollars in thousands) (Unaudited)
                                                                                
                Three                                 Nine                      
                Mont…                                Mont…                      
                Ended                                Ended                      
                Sept…                                Sept…                      
          2026    30,        2025              2026    30,       2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  (lo…    $     (2,5…  )     $     14,9…       $     6,048       $     15,…     
  inc…                                                                          
  Add                                                                           
  bac…                                                                          
  Dep…                                                                          
  and           14,7…              13,2…             43,0…             39,…     
  amo…                                                                          
  Inc…                                                                          
  tax           13,4…              5,935             19,7…             10,…     
  exp…                                                                          
  Int…                                                                          
  exp…          3,832              3,313             9,755             10,…     
  net                                                                           
  Adj…                                                                          
  Non…                                                                          
  sto…          2,925              3,980             10,3…             10,…     
  bas…                                                                          
  com…                                                                          
  Res…                                                                          
  exp…          4,838              3,986             17,4…             10,…     
  net                                                                           
  Unr…                                                                          
  cur…            681              1,865               855             30,…     
  loss                                                                          
  Mer…                                                                          
  and           6,528                  —             34,1…                —     
  acq…                                                                          
  exp…                                                                          
  Lea…                                                                          
  tra…            328                777             1,738             2,9…     
  exp…                                                                          
  Loss                                                                          
  on                                                                            
  sale                                                                          
  of                —                  —                 —             2,1…     
  land                                                                          
  and                                                                           
  bui…                                                                          
  net                                                                           
  Oth…            328                928              (130  )          2,0…     
  (a)                                                                           
  Adj…    $     45,0…        $     49,0…       $     143,…       $     134…     
  EBI…                                                                          
  Pro…    $     405,…        $     386,…       $     1,21…       $     1,1…     
  rev…                                                                          
  Net                                                                           
  (lo…           (0.6  )%            3.9  %            0.5  %           1.4  %  
  inc…                                                                          
  mar…                                                                          
  Adj…                                                                          
  EBI…           11.1  %            12.7  %           11.8  %          12.0  %  
  mar…                                                                          
  (a)                                                                           
  Inc…                                                                          
  a                                                                             
  $1,…                                                                          
  dec…                                                                          
  in                                                                            
  fair                                                                          
  val…                                                                          
  of                                                                            
  an                                                                            
  equ…                                                                          
  inv…                                                                          
  for                                                                           
  the                                                                           
  nine                                                                          
  mon…                                                                          
  end…                                                                          
  Sep…                                                                          
  30,                                                                           
  202…                                                                          
                                                                                
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET INCOME
AND ADJUSTED EARNINGS PER SHARE (Dollars in thousands, except per share data)
(Unaudited)
                                                                                
                Three                                Nine                       
                Mont…                               Mont…                       
                Ended                               Ended                       
                Sept…                               Sept…                       
          2026    30,       2025              2026    30,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  (lo…    $     (2,5…  )    $     14,9…       $     6,048       $     15,2…     
  inc…                                                                          
  Amo…                                                                          
  of                                                                            
  acq…          2,427             1,676             5,802             4,873     
  rel…                                                                          
  int…                                                                          
  Res…                                                                          
  exp…          4,838             3,986             17,4…             10,6…     
  net                                                                           
  Unr…                                                                          
  cur…            681             1,865               855             30,3…     
  loss                                                                          
  Mer…                                                                          
  and           6,528                 —             34,1…                 —     
  acq…                                                                          
  exp…                                                                          
  Lea…                                                                          
  tra…            328               777             1,738             2,935     
  exp…                                                                          
  Loss                                                                          
  on                                                                            
  sale                                                                          
  of                —                 —                 —             2,196     
  land                                                                          
  and                                                                           
  bui…                                                                          
  net                                                                           
  Oth…           (116  )            928              (574  )          2,055     
  Tax                                                                           
  eff…          (2,0…  )          (1,5…  )          (6,5…  )          (13,…  )  
  of                                                                            
  abo…                                                                          
  Adj…                                                                          
  net     $     10,0…       $     22,5…       $     58,9…       $     54,8…     
  inc…                                                                          
  Wei…                                                                          
  ave…                                                                          
  sha…                                                                          
  out…                                                                          
  Bas…          30,6…             30,4…             30,6…             30,6…     
  Dil…          30,6…             30,7…             31,0…             30,8…     
  (Lo…                                                                          
  Ear…                                                                          
  per                                                                           
  sha…                                                                          
  as                                                                            
  rep…                                                                          
  Bas…    $     (0.08  )    $      0.49       $      0.20       $      0.50     
  Dil…    $     (0.08  )    $      0.49       $      0.19       $      0.50     
  Adj…                                                                          
  ear…                                                                          
  per                                                                           
  sha…                                                                          
  Bas…    $      0.33       $      0.74       $      1.93       $      1.79     
  Dil…    $      0.33       $      0.73       $      1.90       $      1.78     
                                                                                
GENTHERM INCORPORATED CONSOLIDATED CONDENSED BALANCE SHEETS (Dollars in
thousands, except share data) (Unaudited)
                                                                                
                              September 30, 2026          December 31, 2025     
 ────────────────────────────────────────────────────────────────────────────── 
  ASSETS                                                                        
  Current Assets:                                                               
  Cash and cash            $             252,098       $            160,833     
  equivalents                                                                   
  Accounts receivable,                   326,217                    281,083     
  net                                                                           
  Inventory:                                                                    
  Raw materials                          127,403                    128,314     
  Work in process                         44,437                     35,429     
  Finished goods                          91,647                     88,959     
  Inventory, net                         263,487                    252,702     
  Other current assets                    85,678                     82,332     
  Total current assets                   927,480                    776,950     
  Property and                           263,561                    270,614     
  equipment, net                                                                
  Goodwill                               122,258                    108,918     
  Other intangible                        63,858                     52,796     
  assets, net                                                                   
  Operating lease                         48,674                     56,524     
  right-of-use assets                                                           
  Deferred income tax                     93,853                     93,552     
  assets                                                                        
  Other non-current                       42,615                     37,075     
  assets                                                                        
  Total assets             $           1,562,299       $          1,396,429     
  LIABILITIES AND                                                               
  SHAREHOLDERS’ EQUITY                                                          
  Current Liabilities:                                                          
  Accounts payable         $             298,183       $            260,487     
  Current lease                            7,846                      9,646     
  liabilities                                                                   
  Current maturities of                      912                         73     
  long-term debt                                                                
  Other current                          144,999                    134,104     
  liabilities                                                                   
  Total current                          451,940                    404,310     
  liabilities                                                                   
  Long-term debt, less                   319,531                    189,000     
  current maturities                                                            
  Non-current lease                       42,469                     48,105     
  liabilities                                                                   
  Pension benefit                          3,281                      3,748     
  obligation                                                                    
  Other non-current                       23,760                     30,943     
  liabilities                                                                   
  Total liabilities        $             840,981       $            676,106     
  Shareholders’ Equity:                                                         
  Common Stock:                                                                 
  No par value;                                                                 
  110,000,000 shares                                                            
  authorized 30,710,902                                                         
  and 30,526,231                                                                
  issued and                              13,442                      5,611     
  outstanding at                                                                
  September 30,                                                                 
  2026 and December 31,                                                         
  2025, respectively                                                            
  Paid-in capital                          1,590                      1,590     
  Accumulated other                      (13,848  )                    (964  )  
  comprehensive loss                                                            
  Accumulated earnings                   720,134                    714,086     
  Total shareholders’                    721,318                    720,323     
  equity                                                                        
  Total liabilities and                                                         
  shareholders’            $           1,562,299       $          1,396,429     
  equity                                                                        
                                                                                
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Dollars
in thousands) (Unaudited)
                                                                                
                         Nine Months Ended                                      
  Operating              September 30,                                          
  Activities:            2026                                2025               
 ────────────────────────────────────────────────────────────────────────────── 
  Net income             $                       6,048       $       15,298     
  Adjustments to                                                                
  reconcile net                                                                 
  income to                                                                     
  net cash provided                                                             
  by operating                                                                  
  activities:                                                                   
  Depreciation and                              44,201               39,478     
  amortization                                                                  
  Deferred income                               (9,548  )           (12,836  )  
  taxes                                                                         
  Stock based                                   10,371               10,573     
  compensation                                                                  
  Loss on disposition                                                           
  of property and                                  121                2,671     
  equipment                                                                     
  Provisions for                                 4,086                5,234     
  inventory                                                                     
  Other non-cash                                                                
  items, including                                                              
  unrealized foreign                            (1,018  )            30,957     
  currency (gain)                                                               
  loss                                                                          
  Changes in assets                                                             
  and liabilities:                                                              
  Accounts                                     (43,474  )           (20,543  )  
  receivable, net                                                               
  Inventory                                    (22,133  )           (20,136  )  
  Other assets                                  (1,403  )           (22,325  )  
  Accounts payable                              43,305               33,514     
  Other liabilities                              5,451               25,935     
  Net cash provided                                                             
  by operating                                  36,007               87,820     
  activities                                                                    
  Investing                                                                     
  Activities:                                                                   
  Purchases of                                                                  
  property and                                 (22,558  )           (33,378  )  
  equipment                                                                     
  Proceeds from the                                                             
  sale of property                                  83                3,770     
  and                                                                           
  equipment                                                                     
  Acquisition of                                                                
  business, net of                             (34,152  )                 —     
  cash                                                                          
  acquired                                                                      
  Cost of technology                              (121  )              (915  )  
  investments                                                                   
  Proceeds from                                                                 
  deferred purchase                                                             
  price of                                           —                  744     
  factored                                                                      
  receivables                                                                   
  Net cash used in                                                              
  investing                                    (56,748  )           (29,779  )  
  activities                                                                    
  Financing                                          —                    —     
  Activities:                                                                   
  Borrowings on debt                           204,000               72,000     
  Repayments of debt                           (85,887  )          (103,112  )  
  Cash paid for                                 (2,761  )                 —     
  financing new loans                                                           
  Taxes withheld and                                                            
  paid on employees'                            (2,540  )            (1,306  )  
  stock based                                                                   
  compensation                                                                  
  Cash paid for the                                                             
  repurchase of                                      —              (10,015  )  
  Common                                                                        
  Stock                                                                         
  Net cash provided                                                             
  by (used in)                                 112,812              (42,433  )  
  financing                                                                     
  activities                                                                    
  Foreign currency                                (806  )             4,508     
  effect                                                                        
  Net increase in                                                               
  cash and cash                                 91,265               20,116     
  equivalents                                                                   
  Cash and cash                                                                 
  equivalents at                               160,833              134,134     
  beginning                                                                     
  of period                                                                     
  Cash and cash                                                                 
  equivalents at end     $                     252,098       $      154,250     
  of                                                                            
  period                                                                        
                                                                                
GENTHERM INCORPORATED OTHER NON-GAAP RECONCILIATIONS (Dollars in thousands)
(Unaudited)
                                                                                
                Three                                Nine                       
                Mont…                               Mont…                       
                Ended                               Ended                       
                Sept…                               Sept…                       
          2026    30,       2025              2026    30,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Tot…                                                                          
  ope…    $     79,9…       $     71,2…       $     251,…       $     206,…     
  exp…                                                                          
  Res…                                                                          
  exp…          (4,8…  )          (3,9…  )          (17,…  )          (10,…  )  
  net                                                                           
  Non…                                                                          
  sto…          (2,8…  )          (3,9…  )          (9,8…  )          (10,…  )  
  bas…                                                                          
  com…                                                                          
  Mer…                                                                          
  and           (6,5…  )              —             (34,…  )              —     
  acq…                                                                          
  exp…                                                                          
  Lea…                                                                          
  tra…           (328  )           (777  )          (1,7…  )          (2,9…  )  
  exp…                                                                          
  Loss                                                                          
  on                                                                            
  sale                                                                          
  of                —                 —                 —             (2,1…  )  
  land                                                                          
  and                                                                           
  bui…                                                                          
  net                                                                           
  Oth…              —              (927  )              —              (927  )  
  Adj…                                                                          
  ope…    $     65,3…       $     61,6…       $     188,…       $     179,…     
  exp…                                                                          
                                                                                
                                                                                
                                   September 30, 2026       September 30, 2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Cash and cash equivalents     $             252,098    $             154,250  
  Revolving line of credit                    242,141                  307,938  
  availability                                                                  
  Total liquidity               $             494,239    $             462,188  
                                                                                
                                                                                
                                   September 30, 2026       September 30, 2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Current maturities of         $                 912    $                 109  
  long-term debt                                                                
  Long-term debt, less                        319,531                  189,000  
  current maturities                                                            
  Total Debt                                  320,443                  189,109  
  Cash and cash equivalents                   252,098                  154,250  
  Net Debt                      $              68,345    $              34,859  
  Adjusted EBITDA for the                                                       
  trailing four                 $             181,034    $             175,620  
  fiscal quarters                                                               
  Net Leverage                                    0.4                      0.2  
                                                                                
                                                                                
                Three                                Nine                       
                Mont…                               Mont…                       
                Ended                               Ended                       
                Sept…                               Sept…                       
          2026    30,       2025              2026    30,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  cash                                                                          
  pro…    $     33,7…       $     56,1…       $     36,0…       $     87,8…     
  by                                                                            
  ope…                                                                          
  act…                                                                          
  Pur…                                                                          
  of                                                                            
  pro…          (8,3…  )          (9,6…  )          (22,…  )          (33,…  )  
  and                                                                           
  equ…                                                                          
  Pro…                                                                          
  from                                                                          
  the                                                                           
  sale             13                25                83             3,770     
  of                                                                            
  pro…                                                                          
  and                                                                           
  equ…                                                                          
  Free                                                                          
  Cash          25,3…             46,4…             13,5…             58,2…     
  Flow                                                                          
  Cash                                                                          
  eff…                                                                          
  of                                                                            
  adj…                                                                          
  Res…                                                                          
  exp…          5,352             2,308             11,9…             6,648     
  net                                                                           
  Mer…                                                                          
  and           11,9…                15             32,9…                15     
  acq…                                                                          
  exp…                                                                          
  Lea…                                                                          
  tra…            989               650             1,015             6,711     
  exp…                                                                          
  Oth…              —             2,103                 —               704     
  Adj…                                                                          
  Free    $     43,6…       $     51,5…       $     59,4…       $     72,2…     
  Cash                                                                          
  Flow                                                                          
                                                                                

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/THRM/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.